Browsing Tag
brensocatib
2 posts
Insmed (NASDAQ: INSM) rebounds as retail eyes ATS 2026 readouts after Q1 reset
INSM bounced 11% after a 20% post-earnings reset. BRINSUPRI is launching faster than any respiratory drug in a decade. So why did the market sell the print?
Insmed enrolls adults in brensocatib phase 3 trial in bronchiectasis
Insmed Incorporated said that it has wrapped up enrollment of adult patients in the ASPEN phase 3 clinical…